| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | $25.00K | $25.00K | – |
| Operating Income | -$890.71K | -$933.94K | -$847.12K | -$1.04M | -$55.65K | -$1.05K |
| Interest Expense | $50.00K | $50.00K | – | – | – | – |
| Tax Expense | $77.10K | $287.24K | $616.19K | $301.50K | – | – |
| Net Income | -$414.68K | $109.37K | $1.60M | $145.51K | -$53.45K | -$1.05K |
| EPS (basic) | – | – | – | 0.5000 | 1.4400 | – |
| EPS (diluted) | – | – | – | 0.5000 | -0.1900 | 0.0000 |
| Shares (diluted) | – | – | – | $5.75M | $157.53K | – |